Quick Answer
Soy Protein Lipid Markers Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: 1 2 3 4 5 4 Excess body weight (i.e., BMI ≥25 kg/mindicating overweight and obesity) and, more specifically, excess adiposity are associated with elevated concentrations of inflammatory markers, including IL-6, IL-8, TNF-α, and C-reactive protein (CRP) [], a condition known as chronic low-grade systemic inflammation.
Key Takeaways
- 011 2 3 4 5 4 Excess body weight (i.e., BMI ≥25 kg/mindicating overweight and obesity) and, more specifically, excess adiposity are associated with elevated concentrations of inflammatory markers, including IL-6, IL-8, TNF-α, and C-reactive protein (CRP) [], a condition known as chronic low-grade systemic inflammation. [Montenegro Julia (2026)]
- 02This inflammatory state contributes to various metabolic abnormalities [], such as insulin resistance (i.e., impaired insulin function leading to elevated fasting insulin and glucose) and dyslipidemia (increased triglycerides, total cholesterol, and LDL cholesterol, and reduced HDL cholesterol) []. [Montenegro Julia (2026)]
- 03For example, increased gut permeability observed in obesity allows higher absorption of bacterial products, triggering a proinflammatory response, further exacerbating chronic low-grade systemic inflammation and metabolic dysfunction [,]. [Montenegro Julia (2026)]
- 04By critically evaluating the available evidence, this review seeks to highlight future directions and opportunities for the use of algae in both nutritional science and clinical medicine, with a particular focus on their potential as sustainable protein sources with functional health effects. [Wang Zixuan (2026)]
The current Migaku evidence database contains 2 reusable source documents for Soy Protein Lipid Markers Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- 1 2 3 4 5 4 Excess body weight (i.e., BMI ≥25 kg/mindicating overweight and obesity) and, more specifically, excess adiposity are associated with elevated concentrations of inflammatory markers, including IL-6, IL-8, TNF-α, and C-reactive protein (CRP) [], a condition known as chronic low-grade systemic inflammation. [Montenegro Julia (2026); evidence level 2]
- This inflammatory state contributes to various metabolic abnormalities [], such as insulin resistance (i.e., impaired insulin function leading to elevated fasting insulin and glucose) and dyslipidemia (increased triglycerides, total cholesterol, and LDL cholesterol, and reduced HDL cholesterol) []. [Montenegro Julia (2026); evidence level 2]
- For example, increased gut permeability observed in obesity allows higher absorption of bacterial products, triggering a proinflammatory response, further exacerbating chronic low-grade systemic inflammation and metabolic dysfunction [,]. [Montenegro Julia (2026); evidence level 2]
- By critically evaluating the available evidence, this review seeks to highlight future directions and opportunities for the use of algae in both nutritional science and clinical medicine, with a particular focus on their potential as sustainable protein sources with functional health effects. [Wang Zixuan (2026); evidence level 4]
- Tetraselmis chuii Phaeodactylum tricornutum Ulva 7 8 9 In addition to protein, other bioactive compounds found in algae, such as polysaccharides and carotenoids, have been shown to exert various beneficial effects on human health. [Wang Zixuan (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources